# Impact of Hemo-dialysis Therapy on Blood Levels of Treprostenil in End Stage Renal Disease Patients With Pulmonary Hypertension

> **NCT01234571** · — · UNKNOWN · sponsor: **Rambam Health Care Campus** · enrollment: 5 (estimated)

## Conditions studied

- Pulmonary Hypertension
- End-Stage Renal Disease
- Hemo-dialysis Therapy

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01234571
- **Lead sponsor:** Rambam Health Care Campus
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-11
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 5 (ESTIMATED)
- **Last updated:** 2010-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01234571

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01234571, "Impact of Hemo-dialysis Therapy on Blood Levels of Treprostenil in End Stage Renal Disease Patients With Pulmonary Hypertension". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01234571. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*